Market Dynamics
Germany’s medical-cannabis prices fell by more than a third in 2025, even as imports more than doubled and the shelf grew more crowded. That leaves less room to absorb the cost of a shipment that gets turned back.
Market Structure · July 2026
Germany grew almost none of the 200-plus tonnes of medical cannabis it used in 2025. Its supply is a chain of six licensed steps, and one step in the middle is where a foreign crop legally becomes a medicine.
German imports rose every quarter of 2025. Demand was never the constraint. — BfArM, May 2026 revision
| Point | Value |
|---|---|
| 1 | 37,686 |
| 2 | 47,707 |
| 3 | 59,076 |
| 4 | 60,772 |
Documentation · April 2026
GACP certification proves the farm. The processor that must accept each batch grades a file the certificate never tested.
The farm’s records are what a Qualified Person certifies against. — European Commission
| Metric | Value |
|---|---|
| EudraLex Annex 16 | 16 |
Origin · April 2026
BfArM’s chart ranks how much medical cannabis Germany imported from each country. That is not the same as where the cannabis was grown, because it is processed into a finished medicine along the way, sometimes in a different country.
Canada and Portugal shipped about three-quarters of Germany’s 2025 imports. — BfArM, March 2026 print
| Metric | Share |
|---|---|
| Canada + Portugal | 74% of 2025 German imports |
The route
Cannventure coordinates the route into Germany without taking title, holding inventory, or holding a licence. The processor, importer, wholesaler, and pharmacy remain the legal holders at each step.